Acute Kidney Injury due to spontaneous Atheroembolic disease, superimposed on diabetic nephropathy, with no recent vascular or cardiac intervention, presented as Rapidly Progressive Glomerulonephritis (RPGN)

Article Sidebar

PDF HTML
Submitted: May 26, 2021
Published: Jul 14, 2021
DOI: 10.29328/journal.jcn.1001074
Crossref
Scopus
Google Scholar
Europe PMC

Main Article Content

Anas Diab*
Department of Medicine, Section of Nephrology, Morgantown, WV 26506, USA
Parravani Anthony
Department of Medicine, Section of Nephrology, Morgantown, WV 26506, USA
Hollie Berryman
Department of Medicine, Section of Nephrology, Morgantown, WV 26506, USA
Kareem Diab
Department of Medicine, Section of Nephrology, Morgantown, WV 26506, USA

Article Details

Diab, A., Anthony, P., Berryman, H., & Diab, K. (2021). Acute Kidney Injury due to spontaneous Atheroembolic disease, superimposed on diabetic nephropathy, with no recent vascular or cardiac intervention, presented as Rapidly Progressive Glomerulonephritis (RPGN). Journal of Clinical Nephrology, 5(2), 053–055. https://doi.org/10.29328/journal.jcn.1001074
Case Reports

Copyright (c) 2021 Diab A, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Kronzon I, Saric M. Cholesterol embolization syndrome. Circulation 2010; 122: 631-641. PubMed: https://pubmed.ncbi.nlm.nih.gov/20697039/

Tanaka H, Yamana H, Matsui H, Fushimi K, Yasunaga H, et al. Proportion and risk factors of cholesterol crystal embolization after cardiovascular procedures: a retrospective national database study. Heart Vessels 2020; 35:1250-1255. PubMed: https://pubmed.ncbi.nlm.nih.gov/32277287/

Nickol J, Richards T, Mullins J. Cholesterol Embolization Syndrome From Penetrating Aortic Ulcer. Cureus 2020; 12: e8670. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370687/

Muller-Hansma AHG, Daemen-Gubbels CRGM, Schut NH. Cholesterol embolisms as possible adverse drug reaction of direct oral anticoagulants. Neth J Med 2018; 76:125-128. PubMed: https://pubmed.ncbi.nlm.nih.gov/29667588/

Scolari F, Ravani P. Atheroembolic renal disease. Lancet 2010; 375: 1650-1660. PubMed: https://pubmed.ncbi.nlm.nih.gov/20381857/

Cosio FG, Zager RA, Sharma HM. Atheroembolic renal disease causes hypocomplementaemia. Lancet 1985; 2: 118-121. PubMed: https://pubmed.ncbi.nlm.nih.gov/2862317/

Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005; 352: 20-28. PubMed: https://pubmed.ncbi.nlm.nih.gov/15635109/

Vaidya PN, Finnigan NA. Atheroembolic Kidney Disease. 2021. PubMed: https://pubmed.ncbi.nlm.nih.gov/29494024/

Matsumura T, Matsumoto A, Ohno M, Suzuki S, Ohta M, et al. A case of cholesterol embolism confirmed by skin biopsy and successfully treated with statins and steroids. Am J Med Sci 2006; 331: 280-283. PubMed: https://pubmed.ncbi.nlm.nih.gov/16702800/